Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • 'Ghatiya' Is...

'Ghatiya' Is Hyperbole, Not Defamation: HC Declines to Restrain Influencers' Criticism of Protein Supplement

Farhat NasimWritten by Farhat Nasim Published On 2025-05-01T19:41:09+05:30  |  Updated On 1 May 2025 7:41 PM IST
Ghatiya Is Hyperbole, Not Defamation: HC Declines to Restrain Influencers Criticism of Protein Supplement
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: In a significant ruling defining the boundaries of free speech and online criticism in the digital age, the Delhi High Court has refused to grant an interim injunction to nutraceutical brand SAN Nutrition Private Limited in its defamation suit against a group of influencers who criticized its protein supplement "Doctor's Choice ISO PRO."

SAN Nutrition through its predecessors SA Nutrition and B.B. Emporio, started the marketing and sale of dietary and nutritional supplement products in 2018 under the trade marks DC DOCTOR’S CHOICE, and other DC DOCTOR’S CHOICE formative marks including the mark DC DOCTOR’S CHOICE ISO PRO.

Justice Amit Bansal, who presided over the matter, held that the defendants’ content was protected under Article 19(1)(a) of the Constitution and fell within the scope of reasonable criticism, truth, and fair comment.

Background: Dispute over Product Reviews and Brand Reputation

The dispute stems from videos posted by several social media influencers, including Kabir Grover, Manish Keshwani, Avijit Roy and defendant no.1 Arpit Mangal, that questioned the quality of SAN Nutrition’s ISO PRO protein supplement. The plaintiff filed a civil suit alleging trademark infringement, defamation, and brand disparagement, claiming the videos had adversely impacted its reputation and sales.

According to the plaint:

“The plaintiff’s sale of its product under the mark DC DOCTOR’S CHOICE ISO PRO has spiralled downwards ever since the impugned videos surfaced on the internet… the impugned videos were brought to the notice of the plaintiff which were disparaging the plaintiff’s product and adversely affecting its business, goodwill and reputation.”

The titles of some of the videos included terms like “SCAM” and appeared on lists such as “7 Worst Protein Powder Brands,” which SAN Nutrition claimed were defamatory.

Petitioner’s Contention

SAN Nutrition contended that the influencers:

Used disparaging language like “ghatiya” (inferior),

Based their claims on unapproved DIY lab kits,

Had affiliations with competitor brands like MuscleBlaze, and

Infringed on their trademarks.

The plaintiff submitted that such actions amounted to trademark infringement, defamation, and unfair trade practices.

They also claimed that the labs used for testing were not certified by FSSAI and that the accusations were misleading. The plaintiff highlighted its strong market presence since 2018, substantial advertising investments, and Rs 18.85 crore annual revenue.

Respondents’ Stand: Informing Consumers and Exposing Discrepancies

Defendant No.1 Arpit Mangal defended the content, stating the purpose was public interest and consumer safety. He claimed the videos were based on actual lab-tested discrepancies between product label claims and tested nutritional values.

“The defendant no.1 is dedicated to the mission of verifying, auditing and reporting on the quality and safety of health products and supplements through stringent laboratory evaluations and aims to be a trustworthy source of news for fitness enthusiasts and professionals.”

The respondents further asserted that the suit was barred by the one-year limitation period for defamation and challenged the maintainability of the case as a commercial dispute. However, the court ruled that the suit contained multiple causes of action and was within limitation due to continuous online access to the videos.

Court's Observations: Truth, Fair Comment, and Satire Are Defenses

Justice Amit Bansal, in a detailed order, ruled in favor of the influencers, observing that the plaintiff had failed to make a prima facie case for defamation or disparagement.

“The plaintiff has not placed any material in justification of the claims made by it on the label of the plaintiff’s product with regard to nutritional information… Even if the plaintiff’s products are manufactured by a third-party, any false claim therein… would be the plaintiff’s responsibility.”

On the use of the term “ghatiya,” the Court remarked:

“In my view, the word ‘ghatiya’ would mean nothing more than ‘sub-standard’/ ‘inferior’ in English. In the opinion of the defendant no.1 based on the aforesaid test results, the products of the plaintiff are sub-standard inasmuch as they are priced higher in comparison to the products of other brands and are not true to the claims made by the plaintiff… In my opinion, at the highest, the use of the term ‘ghatiya’ would be in the nature of an exaggeration or hyperbole, which would not be defamatory per se.”

On the satirical slogan “Doctor has no choice,” the court observed:

“The reference to the plaintiff in the impugned video 6 as ‘DOCTOR HAS NO CHOICE’ is prima facie satirical in nature… such a reference was insufficient to establish malice on the part of the defendant.”

Justice Bansal emphasized the role of influencers in educating the public. It mentioned;

Applying the Bonnard principle, as followed by the Division Bench in Khushwant Singh (supra), the Court did not grant an interim injunction in favour of the plaintiff. The principles that weighed with the Court in not granting the interim injunction in favour of the plaintiff may be summarized below:
(i) It would be unreasonable to place restrictions on the freedom of speech and expression before the full trial takes place;
(ii)Reasonable criticism, comment and parody is largely protected within the right to free speech under the Constitution;
(iii)Even if the plaintiff has received the requisite approvals, it would not mean that the concerns raised by the defendants are not genuine or backed by materials;
(iv)At an interim stage, it cannot be stated that the actions of the defendants are mala fide;
(v)Just because internet publication has wider viewership or a degree of permanence, it would not mean that a different standard for grant of injunction, in variance with the Bonnard principle, would have to be followed. Adopting a different approach would result in disturbing the balance between free speech and the interest of the plaintiff;
(vi)The use of hyperbole and exaggerated forms of speech or parody would not entitle the plaintiff to grant of interim injunction.

Final Ruling: Free Speech Prevails Over Brand Injunction

Concluding the matter, the court declined the plaintiff’s plea for interim relief:

"The plaintiff has failed to show that the defences of ‘truth’ and ‘fair comment’ put up by the defendants are palpably false and/ or are bound to fail at the stage of trial. On a prima facie view, the plaintiff has also failed to make out a case for disparagement against the defendants as it cannot be said that the contents of the impugned videos are false or misleading or have been made in a malicious manner with an objective to cause damage or injury to the plaintiff
“On a prima facie view, no case of actionable defamation or disparagement has been made out against the defendants… the interim injunction sought by the plaintiff is declined.”

Justice Bansal concluded by reinforcing the court’s commitment to upholding free speech:

"Applying the Bonnard principle as approved by the judgements of the Supreme Court as well as this Court, the plaintiff has failed to make out a prima facie case for grant of interim injunction against the defendants and the statements made by the defendants would be entitled to protection of free speech. The plaintiff has also not been able to establish a prima facie case for infringement of trade marks/ copyright against the defendants."
“The balance of convenience would also be in favour of the defendants and granting an interim injunction would be to their prejudice as it would result in putting fetters on their right to freedom of speech and expression guaranteed under Article 19(1)(a) of the Constitution and would also deprive the right of the public at large to receive information on matters of health.”

To view the full order, click the link below:

https://medicaldialogues.in/pdf_upload/san-nutrition-private-limited-v-arpit-mangalwatermark-1708466-285182.pdf
delhi high courtsan nutritiondefamation caseinfluencer marketingdoctor’s choice iso protrademark infringementarpit mangalhealth supplement reviewghatiya remarkparody protectionarticle 19lab testing disputeyoutube criticismnutraceutical regulationonline product reviewdc doctor’s choice
Farhat Nasim
Farhat Nasim

    Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    Prediabetes and the Mind: Unraveling Cognitive and Mental Health Risks

    Prediabetes and the Mind: Unraveling Cognitive and Mental Health Risks

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    View All

    Journal Club Today

    Ajanta Pharma Launches Met-XL D to Improve Outcomes for Heart Failure and Post-Myocardial Infarction Patients

    Ajanta Pharma Launches Met-XL D to Improve Outcomes for Heart Failure and Post-Myocardial Infarction...

    View All

    Health News Today

    Health Bulletin 22/ May/ 2025

    Health Bulletin 22/ May/ 2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok